Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TmPSMA-02 CAR-T cells |
Trade Name | |
Synonyms | TmPSMA 02|TmPSMA-02 |
Drug Descriptions |
TmPSMA-02 CAR-T cells are autologous T-lymphocytes engineered to express a CD2 endodomain-containing chimeric antigen receptor (CAR) targeting PSMA, a dominant negative form of TGFBR2, and a PD-1-CD28 switch receptor, which may induce toxicity against PSMA-expressing tumor cells (J Clin Oncol 40, no. 6_suppl (February 16, 2022) 158, NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C190115 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TmPSMA-02 CAR-T cells | TmPSMA-02 CAR-T cells | 0 | 1 |